In addition, treatment of primary CLL cells or MEC1 cells with AZA increased catalase mRNA levels, further suggesting that promoter methylation regulates catalase level in CLL cells, at least in part. This evidence concerns the gene CAT and B-cell chronic lymphocytic leukemia.